# Modified Versus Conventional Serratus Anterior Plane Block

> **NCT05661253** · NA · UNKNOWN · sponsor: **Zagazig University** · enrollment: 99 (estimated)

## Conditions studied

- Postoperative Pain, Acute

## Interventions

- **DRUG:** 25 ml of bupivacaine 0.25% via serratus anterior block
- **DRUG:** 25 ml of bupivacaine 0.25% via modified serratus anterior palne block

## Key facts

- **NCT ID:** NCT05661253
- **Lead sponsor:** Zagazig University
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-02
- **Primary completion:** 2023-10-02
- **Final completion:** 2023-10-30
- **Target enrollment:** 99 (ESTIMATED)
- **Last updated:** 2023-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05661253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05661253, "Modified Versus Conventional Serratus Anterior Plane Block". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT05661253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*